Genscript Biotech Corporation
GNNSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $2,862,930 | -$350,979 | -$431,690 | -$496,375 |
| Dep. & Amort. | $61,789 | $74,046 | $64,248 | $47,779 |
| Deferred Tax | $0 | $0 | $13,273 | $12,024 |
| Stock-Based Comp. | $76,515 | $60,591 | $65,154 | $39,691 |
| Change in WC | $85,439 | -$150,652 | $169,755 | $121,679 |
| Other Non-Cash | -$3,011,026 | $80,083 | -$1,032 | $138,412 |
| Operating Cash Flow | $75,647 | -$286,911 | -$120,292 | -$136,790 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$146,676 | -$158,082 | -$203,572 | -$137,397 |
| Net Acquisitions | $0 | $0 | -$914 | -$3,762 |
| Inv. Purchases | -$3,364,786 | -$5,743,867 | -$409,620 | -$322,564 |
| Inv. Sales/Matur. | $2,569,237 | $5,660,107 | $187,693 | $243,980 |
| Other Inv. Act. | -$514,138 | -$115,886 | -$16,883 | $7,195 |
| Investing Cash Flow | -$1,456,363 | -$357,728 | -$443,296 | -$212,548 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $44,622 | $49,782 | $32,599 | -$48,894 |
| Stock Issued | $13,486 | $1,030,168 | $423,307 | $951,229 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $8,411 | -$9,280 | -$36,589 | -$194 |
| Financing Cash Flow | $66,519 | $1,068,260 | $419,317 | $902,141 |
| Forex Effect | -$216 | -$1,217 | -$12,701 | -$890 |
| Net Chg. in Cash | -$1,314,413 | $422,404 | -$156,972 | $551,913 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,446,403 | $1,023,999 | $1,180,971 | $629,058 |
| End Cash | $131,990 | $1,446,403 | $1,023,999 | $1,180,971 |
| Free Cash Flow | -$72,273 | -$444,624 | -$323,864 | -$274,187 |